Parkinson named to Zyngenia’s board of directors

David Parkinson, M.D., has been appointed to the board of directors of Zyngenia Inc., a Gaithersburg-based biopharmaceutical company, and named head of its clinical advisory board. He will also serve as interim chief medical officer. From 2007 until 2012, Parkinson served as president and CEO of Nodality, a South San Francisco-based venture-financed biotech company. Before that ...

Leave a Reply

Your email address will not be published. Required fields are marked *